Xiaosu Zhao

4.0k total citations
159 papers, 2.4k citations indexed

About

Xiaosu Zhao is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Xiaosu Zhao has authored 159 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Hematology, 67 papers in Immunology and 27 papers in Molecular Biology. Recurrent topics in Xiaosu Zhao's work include Hematopoietic Stem Cell Transplantation (77 papers), Immune Cell Function and Interaction (48 papers) and Acute Myeloid Leukemia Research (45 papers). Xiaosu Zhao is often cited by papers focused on Hematopoietic Stem Cell Transplantation (77 papers), Immune Cell Function and Interaction (48 papers) and Acute Myeloid Leukemia Research (45 papers). Xiaosu Zhao collaborates with scholars based in China, United States and Hong Kong. Xiaosu Zhao's co-authors include Xiao‐Jun Huang, Ying‐Jun Chang, Lan‐Ping Xu, Kai‐Yan Liu, Xiaohui Zhang, Yu Wang, Xiang Wang, Huan Chen, Dai‐Hong Liu and Ming-Rui Huo and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Blood.

In The Last Decade

Xiaosu Zhao

152 papers receiving 2.4k citations

Peers

Xiaosu Zhao
Tomomi Toubai Japan
Fumihiko Kimura Japan
Isao Tawara Japan
Günther Eißner Germany
C. Darrell Jennings United States
Kai Hübel Germany
Ling Lu China
Thomas J. Podor Canada
Shaohua Chen China
Jonni S. Moore United States
Tomomi Toubai Japan
Xiaosu Zhao
Citations per year, relative to Xiaosu Zhao Xiaosu Zhao (= 1×) peers Tomomi Toubai

Countries citing papers authored by Xiaosu Zhao

Since Specialization
Citations

This map shows the geographic impact of Xiaosu Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaosu Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaosu Zhao more than expected).

Fields of papers citing papers by Xiaosu Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaosu Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaosu Zhao. The network helps show where Xiaosu Zhao may publish in the future.

Co-authorship network of co-authors of Xiaosu Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaosu Zhao. A scholar is included among the top collaborators of Xiaosu Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaosu Zhao. Xiaosu Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jing, Siqi Li, Ying‐Jun Chang, et al.. (2024). Sintilimab plus decitabine for higher-risk treatment-naïve myelodysplastic syndromes: efficacy, safety, and biomarker analysis of a phase II, single-arm trial. Journal for ImmunoTherapy of Cancer. 12(11). e010355–e010355. 3 indexed citations
2.
3.
Zhao, Xiaosu, Meng Lv, Yu Wang, et al.. (2024). LILRB4 Synthetic T-Cell Receptor and Antigen Receptor-T (STAR-T) for Refractory/Relapsed Acute Myeloid Leukemia: First-in-Human Phase I Clinical Trial. Blood. 144(Supplement 1). 4831–4831. 2 indexed citations
4.
Zhao, Xiaosu, et al.. (2023). Signaling pathways in brain ischemia: Mechanisms and therapeutic implications. Pharmacology & Therapeutics. 251. 108541–108541. 22 indexed citations
5.
6.
Wu, Haotian & Xiaosu Zhao. (2022). Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies. International Journal of Biological Sciences. 18(5). 1974–1988. 18 indexed citations
7.
Zhao, Xiaosu, et al.. (2021). MiR-155-5p affects Wilms’ tumor cell proliferation and apoptosis via targeting CREB1. SHILAP Revista de lepidopterología. 5 indexed citations
8.
Zhao, Xiaosu, et al.. (2021). Therapeutic Single Compounds for Osteoarthritis Treatment. Pharmaceuticals. 14(2). 131–131. 18 indexed citations
9.
Wang, Xiang, Xingxing Yu, Zeying Fan, et al.. (2021). Donor activating killer cell immunoglobulin‐like receptors genes correlated with Epstein–Barr virus reactivation after haploidentical haematopoietic stem cell transplantation. British Journal of Haematology. 196(4). 1007–1017. 5 indexed citations
10.
Kim, Dahye, et al.. (2020). GSK5182, 4-Hydroxytamoxifen Analog, a New Potential Therapeutic Drug for Osteoarthritis. Pharmaceuticals. 13(12). 429–429. 6 indexed citations
11.
12.
Qin, Ya‐Zhen, Yao Chen, Lan‐Ping Xu, et al.. (2017). Outcome and Minimal Residual Disease Monitoring in Patients with t(16;21) Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(1). 163–168. 7 indexed citations
13.
Zhao, Xiaosu, et al.. (2014). p35 Regulates the CRM1-Dependent Nucleocytoplasmic Shuttling of Nuclear Hormone Receptor Coregulator-Interacting Factor 1 (NIF-1). PLoS ONE. 9(10). e110584–e110584. 3 indexed citations
14.
15.
16.
Lv, Meng, Xiao‐Su Zhao, Xiaosu Zhao, et al.. (2013). Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation. PLoS ONE. 8(3). e58735–e58735. 12 indexed citations
17.
Zhao, Xiaosu, et al.. (2011). IL‐17‐producing T cells contribute to acute graft‐versus‐host disease in patients undergoing unmanipulated blood and marrow transplantation. European Journal of Immunology. 41(2). 514–526. 53 indexed citations
18.
Zhao, Xiaosu, Ying‐Jun Chang, & Xiao‐Jun Huang. (2011). Conflicting Impact of Alloreactive NK Cells on Transplantation Outcomes after Haploidentical Transplantation: Do the Reconstitution Kinetics of Natural Killer Cells Create These Differences?. Biology of Blood and Marrow Transplantation. 17(10). 1436–1442. 22 indexed citations
19.
Yang, Hong, Chao Zhang, Xiaosu Zhao, et al.. (2010). Analysis of copy number variations of BS69 in multiple types of hematological malignancies. Annals of Hematology. 89(10). 959–964. 9 indexed citations
20.
Chang, Ying‐Jun, Lan‐Ping Xu, Dai‐Hong Liu, et al.. (2009). Platelet Engraftment in Patients with Hematologic Malignancies following Unmanipulated Haploidentical Blood and Marrow Transplantation: Effects of CD34+ Cell Dose and Disease Status. Biology of Blood and Marrow Transplantation. 15(5). 632–638. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomomi Toubai Breakdown of academic impact, for papers by Fumihiko Kimura Breakdown of academic impact, for papers by Isao Tawara Breakdown of academic impact, for papers by Günther Eißner Breakdown of academic impact, for papers by C. Darrell Jennings Breakdown of academic impact, for papers by Kai Hübel Breakdown of academic impact, for papers by Ling Lu Breakdown of academic impact, for papers by Thomas J. Podor Breakdown of academic impact, for papers by Shaohua Chen Breakdown of academic impact, for papers by Jonni S. Moore
Rankless by CCL
2026